OTCMKTS:BIEI Premier Biomedical (BIEI) Stock Price, News & Analysis → Moonshot Coins for the Current Crypto Run (From Crypto 101 Media) (Ad) Free BIEI Stock Alerts $0.0008 0.00 (0.00%) (As of 06/12/2024 ET) Add Compare Share Share Today's Range$0.0008▼$0.001050-Day Range N/A52-Week Range$0.0005▼$0.0017Volume1.03 million shsAverage Volume2.07 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Premier Biomedical alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing demand from Central Banks and billionaires to EXPLODE! The elites are buying up gold like nothing we've seen before… Click here now to download the free Precious Metals Buying Guide. About Premier Biomedical Stock (OTCMKTS:BIEI)Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.Read More BIEI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIEI Stock News HeadlinesMay 13, 2024 | globenewswire.comPremier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced ConcreteApril 17, 2024 | finance.yahoo.comPremier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building MaterialsApril 17, 2024 | globenewswire.comPremier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building MaterialsMarch 7, 2024 | globenewswire.comPremier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)February 13, 2024 | businessinsider.comSouthwest Premier Card Review 2024September 13, 2023 | benzinga.comSANGUINE BIOSCIENCES OPENS NEW APHERESIS DONOR CENTER TO SUPPORT CELL & GENE THERAPY AND TRANSLATIONAL RESEARCH INITIATIVESAugust 25, 2023 | seekingalpha.comBIEI Premier Biomedical, Inc.July 24, 2023 | bbc.co.ukPremier League pre-season fixtures: Where is your club playing this summer?July 23, 2023 | dailymail.co.ukPremier League transfer window: Your comprehensive club-by-club list of all the summer moves in 2023June 7, 2023 | usatoday.comIHG Rewards Premier Credit Card: Elite status at a budget priceMarch 30, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), Welcomes Officers, Directors and Key AdvisorsMarch 16, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., collaborates with Oklahoma Based “Biographene Technology Inc”, for its Graphene ProductionFebruary 28, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC: BIEI), now known as Premier Graphene, Inc., specifies plans and timing for development of its Full Scale, Seed To Product Delivery, Graphene InitiativeFebruary 1, 2023 | finance.yahoo.comNova Graphene Ballistics (OTC PINK: BIEI) Retains Award Winning Communication Firm To Expand Public MessagingJanuary 19, 2023 | finance.yahoo.comPremier Biomedical Inc. (OTC PINK: BIEI), now known as Nova Graphene Ballistics, Inc., Releases its Graphene Ballistic Plate Production ApproachDecember 20, 2022 | finance.yahoo.comPremier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production MethodologyDecember 14, 2022 | benzinga.comPremier Biomedical Stock (OTC:BIEI), Earnings Estimates, EPS, and RevenueAugust 12, 2022 | apnews.comBIOMEDevice Boston Brings Back “Master Class Start-Up Series” in Partnership with MassMEDICAugust 8, 2022 | ca.finance.yahoo.comPremier Biomedical, Inc. (BIEI)May 17, 2022 | apnews.comBioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease ProjectOctober 26, 2021 | finance.yahoo.comPremier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical OfficerSeptember 3, 2021 | investing.comPremier Biomedical Inc (BIEI)See More Headlines Receive BIEI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BIEI CUSIPN/A CIK1515740 Webwww.premierbiomedical.com Phone724-633-7033FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. David CaplanPresident, Chairman of the Board of Directors, Secretary & TreasurerMr. Gustavo CarreñoChief Technology OfficerMr. Carl EllerMarketing & Planning Vice-PresidentKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors BIEI Stock Analysis - Frequently Asked Questions How have BIEI shares performed in 2024? Premier Biomedical's stock was trading at $0.0009 at the beginning of the year. Since then, BIEI shares have decreased by 11.1% and is now trading at $0.0008. View the best growth stocks for 2024 here. What other stocks do shareholders of Premier Biomedical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premier Biomedical investors own include Co-Diagnostics (CODX), Allena Pharmaceuticals (ALNA), CytoDyn (CYDY), Inovio Pharmaceuticals (INO), Sierra Oncology (SRRA), Vaxart (VXRT), MEI Pharma (MEIP), Novavax (NVAX), Rigel Pharmaceuticals (RIGL) and Selecta Biosciences (SELB). How do I buy shares of Premier Biomedical? Shares of BIEI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIEI) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted t...Stansberry Research | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premier Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Premier Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.